Medication
AG-Valacyclovir
DIN 02500582 · Angita Pharma Inc. Likely a generic
What it is
- Active ingredients
- Valacyclovir — 500 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2022-03-25
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Valtrex
- Apo-Valacyclovir
- PMS-Valacyclovir
- Pro-Valacyclovir
- Riva-Valacyclovir
- Sandoz Valacyclovir
- Mylan-Valacyclovir
- Teva-Valacyclovir
- Auro-Valacyclovir
- Jamp Valacyclovir
- Valacyclovir
- Valacyclovir
- NB-Valacyclovir
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Anti-infectives for systemic use
- ATC code
- J05AB11
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of J05AB11, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.